Amerra Capital Management-owned Biomega appointed Sten Estrup as its new CEO. Estrup will assume the new role 1 October 2019.

Estrup joins Biomega Group from a position as executive vice president of Asia Pacific & Latin America at Chr. Hansen, a bioscience company that develops natural solutions for the food, nutritional, pharmaceutical and agricultural industries.

The executive comes with 25 years’ experience across the food and health industry in executive roles in operations, sales, marketing and commercial development.

“I am honored to join Biomega and work with the team, partners, customers and the owner Amerra to release the true potential of Biomega’s leading technology for human grade ingredients," said Estrup.